Funding for this research was provided by:
National Institutes of Health (DK064539, DK096606, DK048351)
Vetenskapsrådet (21692, 13409, 21691)
Received: 1 October 2018
Accepted: 7 March 2019
First Online: 21 March 2019
Ethics approval and consent to participate
: All subjects were given verbal and written information about the study prior to providing written informed consent to participate. The Regional Ethical Review Board in Gothenburg approved the study before the start of subject inclusion.
: Not applicable.
: JSL, VO, EYH, AG, KT, CG, ML, LO, and HT have nothing to declare. BLN, MD, and JT are employees of Danone Nutricia Research. MS received unrestricted research grants from Danone Nutricia Research and Ferring Pharmaceuticals, and served as a Consultant/Advisory Board member for AstraZeneca, Danone, Nestlé, Almirall, Allergan, Albireo, Glycom, and Shire, and as a speaker for Tillotts, Menarini, Takeda, Shire, Allergan, and Almirall. EAM is a scientific advisory board member of Dannon, Danone, DanoneWave, Axial Biotherapeutics, Viome, Amare, and Pharmavite.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.